Stocks-REGN-Regeneron Pharmaceuticals

REGN Regeneron Pharmaceuticals

951.11 0 (0%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Trade

Regeneron Pharmaceuticals price

0% Past Week
Market Cap
104.63B
Day’s Range
942.87
-
955.34
52W Range
683.29
-
969.23
Volume (3M)
574.96K
Price-Earnings Ratio
27.43
Revenue
13.12B

Regeneron Pharmaceuticals Latest News

View All
Pinned Post
Cancer Treatment Stocks
Novartis to acquire cancer-focused MorphoSys for $2.9 billion. 💊 Drugmaker $NVS (Novartis ADR) said it will acquire $MOR.DE (MorphoSys), a developer of cancer treatments, for €2.7 billion, adding a promising rare bone-marrow cancer treatment candidate to its portfolio. German biotech firm's shares... Show More
Like CommentShare
Show more comments2 of 3
null
.
Top Discussions

Analyst Forecast

Consensus
Strong Buy
Price Target
1,046.15

ESG: A New Source of Insight

Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
56
High
Industry 
Avg. 45 
59
Environment
57
Social
54
Governance

People Also Bought